These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2834250)

  • 1. Glomerular Na+-K+-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition.
    Cohen MP; Klepser H
    Diabetes; 1988 May; 37(5):558-62. PubMed ID: 2834250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldose reductase, glomerular metabolism, and diabetic nephropathy.
    Cohen MP
    Metabolism; 1986 Apr; 35(4 Suppl 1):55-9. PubMed ID: 3007926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced glomerular sodium/potassium adenosine triphosphatase activity in acute streptozocin diabetes and its prevention by oral sorbinil.
    Cohen MP; Dasmahapatra A; Shapiro E
    Diabetes; 1985 Nov; 34(11):1071-4. PubMed ID: 2995180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
    Yeh LA; Rafford CE; Goddu KJ; Ashton MA; Beyer TA; Hutson NJ
    Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diabetes and Sorbinil treatment on phospholipid metabolism in rat glomeruli.
    Cohen MP; Klepser H; Cua E
    Biochim Biophys Acta; 1986 Apr; 876(2):226-32. PubMed ID: 3006784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A; Ku L; Cohen MP
    Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
    Greene DA; Mackway AM
    Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors.
    Sredy J; Flam BR; Sawicki DR
    Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase inhibition, glomerular metabolism, and diabetic nephropathy.
    Cohen M
    Diabet Med; 1985 May; 2(3):203-6. PubMed ID: 3032499
    [No Abstract]   [Full Text] [Related]  

  • 10. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
    Craven PA; DeRubertis FR
    Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of myo-inositol on renal Na-K-ATPase in experimental diabetes.
    Cohen RA; MacGregor LC; Spokes KC; Silva P; Epstein FH
    Metabolism; 1990 Oct; 39(10):1026-32. PubMed ID: 2170818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
    Obrosova IG; Fathallah L
    Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione redox state is not the link between polyol pathway activity and myo-inositol-related Na+-K+-ATPase defect in experimental diabetic neuropathy.
    Carroll PB; Thornton BM; Greene DA
    Diabetes; 1986 Nov; 35(11):1282-5. PubMed ID: 3019809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct stimulation of Na+-K+-ATPase and its glucosylated derivative by aldose reductase inhibitor.
    Garner MH; Spector A
    Diabetes; 1987 Jun; 36(6):716-20. PubMed ID: 3032716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of Na+, K(+)-ATPase to delayed motor nerve conduction velocity: effect of aldose reductase inhibitor, ADN-138, on Na+, K(+)-ATPase activity.
    Hirata Y; Okada K
    Metabolism; 1990 Jun; 39(6):563-7. PubMed ID: 2161992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of glucose-induced (Na+, K+)-ATPase inhibition in aortic wall of rabbits.
    Simmons DA; Winegrad AI
    Diabetologia; 1989 Jul; 32(7):402-8. PubMed ID: 2553515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR; Hawthorne JN; Tomlinson DR
    Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH; Ross IS
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
    Bank N; Mower P; Aynedjian HS; Wilkes BM; Silverman S
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.